Kumar D,Garg I,Sarwar AH,Kumar L,Kumar V,Ramrakhia S .2021 .5): e15301. Cureus, 13 : .
Hsieh YP,Chang CC,Wen YK,Chiu PF,Yang YJPDI .2012 .Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan-10 years' experience in a single center. Perit Dial Int, 34(1) : 85-94.
Clements TW,Tolonen M,Ball CG,Kirkpatrick AW .2021 .Secondary peritonitis and intra-abdominal sepsis: an increasingly global disease in search of better systemic therapies. Scand J Surg, 110(2) : 139-49.
Ross JT,Matthay MA,Harris HW .2018 .Secondary peritonitis: principles of diagnosis and intervention. BMJ, 361 : .
Pörner D,Von Vietinghof S,Nattermann J,Strassburg CP,Lutz P. .2021 .Advances in the pharmacological management of bacterial peritonitis. Expert Opin Pharmacother, 22(12) : 1567-78.
Wiest R,Krag A,Gerbes A .2012 .Spontaneous bacterial peritonitis: recent guidelines and beyond. -300779, 61(2) : 297-310.
Vaid U,Kane GC .2017 .. Tuberculous Peritonitis; Chapter, 26 : 433.
Mor P,Dahiya B,Parshad S,Gulati P,Mehta PK .2022 .Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests. Expert Rev Gastroenterol Hepatol, 202106(1) : 8-49.
Tekes G,Thiel HJ .2016 .Feline coronaviruses: pathogenesis of feline infectious peritonitis. Adv Virus Res, 08(1) : 193-218.
Pramod J,Vijayakumar C,Srinivasan K,Maroju NK,Kumar NR,Balasubramaniyan G. .2018 .3): e2275. Cureus, 10 : .
Marciano S,Diaz JM,Dirchwolf M,Gadano A .2019 .Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med, 11 : 13-22.
Doklestić S,Bajec D,Djukić R,Bumbaširević V,Detanac A,Detanac S .2014 .Secondary peritonitis-evaluation of 204 cases and literature review. J Med Life, 7(2) : 132-8.
Ballus J,Lopez-Delgado JC,Sabater-Riera J,Perez-Fernandez XL,Betbese A,Roncal JA .2015 .Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes. BMC Infect Dis, 15 : 304.
Mishra SP,Tiwary SK,Mishra M,Gupta SK .2014 .An introduction of tertiary peritonitis. J Emerg Trauma Shock, 7(2) : 130883-2700.
.2016 .Sclerosing encapsulating peritonitis. Sultan Qaboos Univ Med J, 16(2) : e142-e51.
Lindsey WT,Olin BR,Hansen RA,Bentley JP,McGraw-Hill Education JP .2020 .Systematic Review and MetaAnalysis. Aparasu RR, 14 : 151.
Moher D,Liberati A,Tetzlaf J,Altman DG .2009 .Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med, 151(4) : 200908180-9.
Alonso-Coello P,Schünemann HJ,Moberg J,BrignardelloPetersen R,Akl EA,Davoli M .2016 .GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. BMJ, 353 : .
Guevara M,Terra C,Nazar A,Solà E,Fernández J,Pavesi M .2012 .Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol, 06(4) : 759-65.
Niu B,Kim B,Limketkai BN,Sun J,Li Z,Woreta T .2018 .Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA. Dig Dis Sci, 63(5) : 1327-33.
Piano S,Fasolato S,Salinas F,Romano A,Tonon M,Morando F .2016 .The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology, 63(4) : 1299-309.
Thirumalagiri VR,Reddy SR,Chandra H .2017 .Acute peritonitis secondary to hollow viscous perforation: a clinical study. Int Surg J, 4(7) : 2349-2902.
How J,Azar MM,Meyer JP .2015 .Are nectarines to blame? A case report and literature review of spontaneous bacterial peritonitis due to Listeria monocytogenes. Conn Med, 79(1) : 31-6.
Levallois J,Nadeau-Fredette AC,Labbé AC,Laverdiere M,Ouimet D,Vallée M .2011 .Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. Int J Infect Dis, 09(1) : e41-e3.
Doklestić S,Bajec D,Djukić R,Bumbaširević V,Detanac A,Detanac S .2014 .Secondary peritonitis-evaluation of 204 cases and literature review. J Med Life, 7(2) : 132-8.
Salzer WL .2018 .Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis, 11(1) : 173-86.
Nadeau-Fredette AC,Bargman JM .2013 .Characteristics and outcomes of fungal peritonitis in a modern North American cohort. Perit Dial Int, 35(1) : 78-84.
Lahmer T,Brandl A,Rasch S,Schmid RM,Huber W. .2016 .7): e0158389. PLoS One, 11 : .
Pauwels S,De Moor B,Stas K,Magerman K,Gyssens IC,Van Ranst M .2012 .Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: a case report and brief review of the literature. Clin Microbiol Infect, 03985(10) : 0691-E4.
Montravers P,Blot S,Dimopoulos G,Eckmann C,Eggimann P,Guirao X .2016 .Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med, 42(8) : 1234-47.
Gioia F,Gomez-Lopez A,Alvarez ME,de la Pedrosa EGG,Martín-Davila P,Cuenca-Estrella M .2020 .Pharmacokinetics of echinocandins in suspected candida peritonitis: a potential risk for resistance. Int J Infect Dis, 09(1) : 24-8.
Grau S,Luque S,Campillo N,Samso E,Rodriguez U,GarciaBernedo C .2015 .Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis. J Antimicrob Chemother, 70(10) : 2854-61.
Hall RG,Swancutt MA,Meek C,Lef R,Gumbo T. .2013 .Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or threefourths. Antimicrob Agents Chemother, 57(5) : 12-64.
Rhodes A,Evans LE,Alhazzani W,Levy MM,Antonelli M,Ferrer R .2016 .Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock. Intensive Care Med, 43(3) : 304-77.
Kalil AC,Johnson DW,Lisco SJ,Sun J .2017 .Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med, 45(4) : 607-14.
Li PKT,Szeto CC,Piraino B,de Arteaga J,Fan S,Figueiredo AE .2016 .ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int, 36(5) : 481-508.
Sorribas M,Jakob MO,Yilmaz B,Li H,Stutz D,Noser Y .2019 .FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J Hepatol, 06(6) : 1126-40.
Ho PP,Steinman L PP .2016 .Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA, 113(6) : 1600-5.
Gege C,Hambruch E,Hambruch N,Kinzel O,Kremoser C . .Nonsteroidal FXR ligands: current status and clinical applications. , : .
Cho Y,Johnson DW .2014 .Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis, 02(2) : 278-89.
Sahlawi MA,Wilson G,Stallard B,Manera KE,Tong A,Pisoni RL .2020 .Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int, 40(2) : 132-40.
Zheng Q,Zhu R,Yin Z,Xu L,Sun H,Yu H .2022 .Structural basis for the synergistic neutralization of coxsackievirus B1 by a tripleantibody cocktail. Cell Host Microbe, 08(9) : 1279-94.
Fernández J,Piano S,Bartoletti M,Wey EQ .2020 .Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol, 11(Supp 1) : S101-S17.